You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

Iohexol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for iohexol and what is the scope of patent protection?

Iohexol is the generic ingredient in ten branded drugs marketed by Interpharma Praha As and Ge Healthcare, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for iohexol. Three suppliers are listed for this compound.

Summary for iohexol
US Patents:0
Tradenames:10
Applicants:2
NDAs:3
Drug Master File Entries: 3
Finished Product Suppliers / Packagers: 3
Raw Ingredient (Bulk) Api Vendors: 98
Clinical Trials: 66
Patent Applications: 6,410
What excipients (inactive ingredients) are in iohexol?iohexol excipients list
DailyMed Link:iohexol at DailyMed
Recent Clinical Trials for iohexol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Allergy and Infectious Diseases (NIAID)Phase 4
Alexander FlanneryPhase 4
St. Olavs HospitalPhase 4

See all iohexol clinical trials

Pharmacology for iohexol
Medical Subject Heading (MeSH) Categories for iohexol

US Patents and Regulatory Information for iohexol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare OMNIPAQUE 240 iohexol SOLUTION;INJECTION, ORAL, RECTAL 018956-002 Dec 26, 1985 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ge Healthcare OMNIPAQUE 210 iohexol INJECTABLE;INJECTION 018956-006 Jun 30, 1989 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ge Healthcare OMNIPAQUE 300 iohexol SOLUTION;INJECTION, ORAL, RECTAL 018956-003 Dec 26, 1985 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ge Healthcare OMNIPAQUE 350 iohexol SOLUTION;INJECTION, ORAL 020608-003 Oct 24, 1995 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for iohexol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare OMNIPAQUE 240 iohexol SOLUTION;INJECTION, ORAL, RECTAL 018956-002 Dec 26, 1985 ⤷  Sign Up ⤷  Sign Up
Ge Healthcare OMNIPAQUE 350 iohexol SOLUTION;INJECTION, ORAL 018956-004 Dec 26, 1985 ⤷  Sign Up ⤷  Sign Up
Ge Healthcare OMNIPAQUE 180 iohexol SOLUTION;INJECTION, ORAL, RECTAL 018956-001 Dec 26, 1985 ⤷  Sign Up ⤷  Sign Up
Ge Healthcare OMNIPAQUE 240 iohexol SOLUTION;INJECTION, ORAL, RECTAL 018956-002 Dec 26, 1985 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.